CMC

The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies

Jesse McCool, Ph.D.; David Schmidt, M.B.A., M.Sc.; Oren Beske, Ph.D.; Stephen Monks, Ph.D.

Wheeler Bio

Preclinical Data

Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data

Mark Mintz; Kristen M. Eisenhauer

Charles River Laboratories

Cloud-Based Platform

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

Charles River Laboratories

Analytical Services

Expecting More for Drug Discovery and Development

Inotiv

Tissue Models

Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity

Ron Laethem, Ph.D.

Altis Biosystems

Toxicology

SCYNEXIS Reports Completion of Chronic Nonclinical Toxicology Studies Supporting Long-Term Administration of Ibrexafungerp

SCYNEXIS

FDA

FDA Purchases Bundle of ADMET Predictor® Licenses

Simulations Plus, Inc.

Pharmacokinetic Study

Galmed Reports Positive Results From Pharmacokinetic Split Dose Study of Aramchol

Galmed Pharmaceuticals Ltd.

Acquisition

Frontage Acquires Concord Biosciences, Adding Preclinical, Agrochemical and Toxicology Services to the Existing Product Development Portfolio

Frontage

Acquistion

BioIVT Acquires Ascendance Biotechnology, Expanding its Drug Safety Testing and Toxicology Portfolios 

BioIVT